MASI241220C100000
- 49.00
- 0.000.00%
Masimo Newsroom
Masimo Refocuses on Core Healthcare Operations
Express News | Masimo Corp - Terminates Executive Vice President Tao Levy
Masimo Appoints Michelle Brennan as Interim CEO
Correction to Masimo Terminates Founder Kiani as CEO on Oct. 29
Assessing MedTech Impact From Potential China Tariffs
Is There An Opportunity With Masimo Corporation's (NASDAQ:MASI) 44% Undervaluation?
Masimo Third Quarter 2024 Earnings: EPS Misses Expectations
4 Analysts Assess Masimo: What You Need To Know
Masimo's Q3 Earnings Rise Y/Y, Healthcare Demand Drives Growth
Masimo Stock Soars to 52-week High, Hits $173.9 Amid Robust Growth
Wells Fargo Maintains Masimo(MASI.US) With Buy Rating, Maintains Target Price $171
Piper Sandler Maintains Masimo(MASI.US) With Buy Rating, Raises Target Price to $180
Stifel Maintains Masimo(MASI.US) With Buy Rating, Maintains Target Price $170
Masimo Is Maintained at Overweight by Piper Sandler
A Quick Look at Today's Ratings for Masimo(MASI.US), With a Forecast Between $170 to $180
Masimo Price Target Raised to $180 From $165 at Piper Sandler
Masimo Upgraded to Outperform From Market Perform at Raymond James
Masimo (MASI) Gets a Hold From Needham
Masimo | 10-Q: Q3 2024 Earnings Report
Express News | Needham Reiterates Hold on Masimo